Publication Date: January 23, 2018
The merger between Linde and Praxair offers alternative investment avenues: some funds are fixated on the ‘back-end’ squeeze-out in Linde, while others focus on the Linde untendered versus tendered share class trade. Many are combining these strategies and mix in a little merger arb. At this stage, we believe that deviating from the strict merger arbitrage situation introduces market-related risks and we refrain from looking beyond the deal at hand. In this research report, we offer our view on whether the merger can clear global antitrust scrutiny, and the implications and break scenarios if it does not.
1. Antitrust: Industry Dynamics and Likely Assessments by Regulators 2. Antitrust: Market Shares, Overlaps and Issues in Key Regions 3. Break Prices and an Analysis of Recent Operations 4. The Break Spread and Risk Arbitrage Trading Considerations 5. Deal Structure and Timing 6. Strategic Rationale and Accretion/Dilution Numbers
Please contact us to request access to this report or to enquire about our research services.